What Happens to Weight When You Stop GLP-1 Drugs? A Review of the Evidence | Research

The takeaway

Randomized trial evidence shows significant weight regain after stopping liraglutide, semaglutide, or tirzepatide, raising concerns about long-term treatment plans.

Weight regain
Consistent across RCTs for all three agents after treatment discontinuation

What the researchers found

Weight regain after GLP-1 drug discontinuation is substantial and consistent across randomized trials for liraglutide, semaglutide, and tirzepatide.

Why it matters

If weight returns after stopping, patients face a choice between lifelong medication use or accepting weight regain — with major cost and safety implications.

The numbers in context

Reviews RCTs for liraglutide, semaglutide, and tirzepatide; weight regain of approximately two-thirds of lost weight within 1-2 years post-discontinuation.

How the study worked

Narrative review of RCTs from PubMed, Cochrane Library, and Google Scholar published in the last 10 years.

Who was studied

Adults treated with GLP-1 RAs or tirzepatide for obesity

What this study cannot tell us

Narrative review — does not quantitatively pool results. Limited long-term post-discontinuation data available.

How to read the evidence

Narrative review of RCTs — high-quality source studies but review methodology is not systematic.

When this study was published

Published in 2025, addressing one of the most pressing questions about GLP-1 obesity treatment.

The bigger picture

The weight regain problem challenges the healthcare system to decide whether GLP-1 drugs are lifelong commitments or bridges to other interventions.

Questions still open

Can lifestyle changes during treatment prevent weight regain after stopping?
Is intermittent dosing a viable strategy to reduce costs while maintaining benefits?

Common questions

Will I gain weight back if I stop Ozempic or Wegovy?

Research consistently shows significant weight regain after stopping GLP-1 drugs, though the amount and speed vary by medication.

Do I have to take GLP-1 drugs forever?

Current evidence suggests long-term use is needed to maintain weight loss. Discuss with your doctor whether lifelong treatment or alternative strategies are right for you.

Read the original research

Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies.

Journal of clinical medicine, 14(11)

View on PubMed ↗Publisher’s paper ↗

Citation

Quarenghi, Massimo; Capelli, Silvia; Galligani, Giulia; Giana, Arianna; Preatoni, Giorgia; Turri Quarenghi, Rosamaria. (2025). Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies.. Journal of clinical medicine, 14(11). https://doi.org/10.3390/jcm14113791